Amici Clinical Research

Raritan, New Jersey 08869

0 studies enrolling now · 9 studies all time

What they study most

COVID-19, Clostridium Difficile Associated Disease, Clostridium Difficile Infection, Episodic Migraine, Non-alcoholic Steatohepatitis, Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis With Liver Fibrosis, Respiratory Syncytial Virus Infections, SARS-CoV-2 Infection

Studies at this site

• Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals — Completed
• Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) — Completed
• MVA-BN-RSV Vaccine Trial — Stopped early
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis — Stopped early
• Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study — Completed
• Clostridium Difficile Vaccine Efficacy Trial — Completed
• Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age — Completed
• AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine — Completed